SJ PHARMACEUTICALS, LLC – Trademark Portfolio

Entity Type: 16

SJ PHARMACEUTICALS, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include SJP, UTA, and CARDIOTEK. The owner is based in ATLANTA, GA.

4200 NORTHSIDE PARKWAY NW, BLDG 12

ATLANTA, GA 30327

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

URAPUR
URAPUR
Abandoned 2009
SJP
SJP
Registered 2006
RYNEZE
RYNEZE
Cancelled 2005
NOTUSS
NOTUSS
Cancelled 2004
UTA
UTA
Registered 2004
MEDENT
MEDENT
Cancelled 2003
CARDIOTEK
CARDIOTEK
Registered 1998

Trademark Classifications

SJ PHARMACEUTICALS, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SJ PHARMACEUTICALS, LLC have?

SJ PHARMACEUTICALS, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 3 cancelled.

What trademark classes does SJ PHARMACEUTICALS, LLC file in?

SJ PHARMACEUTICALS, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SJ PHARMACEUTICALS, LLC's most well-known trademarks?

SJ PHARMACEUTICALS, LLC's registered trademark portfolio includes well-known marks such as SJP, UTA, and CARDIOTEK. These are among 3 currently registered trademarks in the portfolio.

What is SJ PHARMACEUTICALS, LLC's trademark registration success rate?

SJ PHARMACEUTICALS, LLC has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.